Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) PT Raised to $69 at Cowen Following 'Beat and Raise'

July 20, 2017 6:07 AM
Cowen analyst Ritu Baral raised its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $69.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles